How does Mereo Biopharma Group Plc ADR (MREO) change from a tortoise to a hare?

With 1.19 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.49 million shares. The 52-week range on MREO shows that it touched its highest point at $5.02 and its lowest point at $1.58 during that stretch. It currently has a 1-year price target of $7.30. Beta for the stock currently stands at 0.51.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MREO was down-trending over the past week, with a drop of -7.72%, but this was up by 30.60% over a month. Three-month performance dropped to -25.55% while six-month performance fell -44.16%. The stock lost -26.69% in the past year, while it has lost -31.71% so far this year. A look at the trailing 12-month EPS for MREO yields -0.29 with Next year EPS estimates of -0.03. For the next quarter, that number is -0.01. This implies an EPS growth rate of 26.19% for this year and 36.02% for next year. EPS is expected to grow by 17.79% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 34.82%.

Float and Shares Shorts:

At present, 155.15 million MREO shares are outstanding with a float of 139.69 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for MREO since 2 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.0981746 being high and -$0.0981746 being low. For MREO, this leads to a yearly average estimate of -$0.0490873.